A new intraperitoneal tumor model in the rat.

Area of Science:

• Oncology
• Surgical Oncology
• Preclinical Cancer Models

Background:

• Intraperitoneal chemotherapy requires effective preclinical models for drug testing.
• Existing models may not accurately reflect the complexities of peritoneal tumor growth and treatment response.

Purpose of the Study:

• To develop and validate a new rat model for assessing intraperitoneal chemotherapy.
• To establish a quantitative method for monitoring tumor growth and response to treatment in the peritoneal cavity.

Main Methods:

• Induction of single intraperitoneal tumors in rats via implantation of subcutaneous tumor fragments.
• Monitoring tumor growth using serial laparotomies and caliper measurements.
• Cell kinetic studies to determine tumor doubling time and cell loss.
• Assessment of chemotherapeutic agent (cisplatin) effects on tumor regression and regrowth.

Main Results:

• Untreated intraperitoneal tumors exhibited linear growth (diameter (mm) = 0.39 t (days) + 2.4).
• Tumor volume-doubling time was 3.9 days with a high cell-loss factor (>70%).
• The model allowed satisfactory monitoring of tumor regression and regrowth following cisplatin treatment, enabling estimation of growth delay.

Conclusions:

• A reliable and quantitative rat model for intraperitoneal tumors has been established.
• This model is suitable for evaluating the efficacy of intraperitoneal chemotherapy.
• The model facilitates the quantitative assessment of tumor response, including growth delay, to chemotherapeutic agents.